NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Week of May 4:
Adaptimmune Therapeutics plc – Abingdon, U.K., 9.375 million American depositary shares, each representing 6 ordinary shares, priced $15 to $17, managed by BofA Merrill Lynch, Cowen & Co., and Leerink. Proposed Nasdaq symbol ADAP. Business: Developing cancer immunotherapies based on genetically engineered T-cell receptors.
Anterios Inc. – New York, 3.9 million shares, priced $12 to $14, managed by Stifel, and RBC. Proposed Nasdaq symbol ANTE. Business: Developing a topical formulation of botulinum toxin.
aTyr Pharma Inc. – San Diego, 5.4 million shares, priced $13 to $15, managed by J.P. Morgan, and Citigroup. Proposed Nasdaq symbol LIFE. Business: Developing restorative protein therapeutics for rare muscular dystrophies.
Bojangles’ Inc. – Charlotte, N.C., 6.3 million shares, priced $15 to $17, managed by BofA Merrill lynch, Wells Fargo, and Jefferies. Proposed Nasdaq symbol BOJA. Business: Restaurant chain known for its chicken and biscuits with over 600 locations.
Collegium Pharmaceutical Inc. – Canton, Mass., 5.8 million shares, priced $12 to $14, managed by Jefferies, and Piper Jaffray. Proposed Nasdaq symbol COLL. Business: Developing an abuse-deterrent oral formulation of oxycodone for pain.
Commercial Credit Inc. – Charlotte, N.C., 7.3 million shares, priced $15 to $17, managed by J.P. Morgan, and Keefe Bruyette Woods. Proposed NYSE symbol CCR. Business: Provides commercial equipment loans to middle-market companies.
Gelesis Inc. – Boston, 4 million shares, priced $12 to $14, managed by Piper Jaffray, Stifel, and Guggenheim. Proposed Nasdaq symbol GLSS. Business: Developing a weight loss capsule for patients with obesity and type 2 diabetes.
HTG Molecular Diagnostics Inc. – Tucson, Ariz., 3.6 million shares, priced $13 to $15, managed by Leerink. Proposed Nasdaq symbol HTGM. Business: Markets a diagnostic platform for complex molecular profiling.
International Market Centers Inc. – Las Vegas, Nev., 11.5 million shares, priced $12 to $14, managed by Barclays, Credit Suisse, and Wells Fargo. Proposed NYSE symbol IMC. Business: Owns furniture trade show centres in Las Vegas, Nev. and High Point, N.C.
Klox Technologies Inc. – Laval, Quebec, Canada, 4.8 million shares, priced $13 to $15, managed by UBS. Proposed Nasdaq symbol KLOX. Business: Developing a light-reactive topical gel for acne and skin care.
MultiVir Inc. – Houston, 4.6 million shares, priced $12 to $14, managed by RBC. Proposed Nasdaq symbol MVIR. Business: Biotech developing gene therapies for cancer.
Tallgrass Energy GP LP – Leawood, Kan., 35.3 million class A shares, priced $24 to $27, managed by Citigroup, Goldman Sachs, and BofA Merrill Lynch. Proposed NYSE symbol TEGP. Business: Holds GP and LP interests in midstream natural gas LP Tallgrass Energy.